Neovascularization, Pathologic - 25 Studies Found
Completed |
: Bevacizumab Intravitreal for Myopic Choroidal Neovascularization : Myopic Choroidal Neovascularization : 2008-11-24 : Drug: Injection Intravitreal injection of 1.25 mg bevacizumab |
Completed |
: Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. : Choroidal Neovascularization (CNV) : 2013-04-23 :
|
Active, not recruiting |
: Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia : Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia : 2012-10-25 : Drug: Bevazizumab intravitreal injection Intravitreal injection of bevacizumab |
Active, not recruiting |
: Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular Diseases : Neovascularization, Pathologic : 2015-05-15 : Drug: ACM-1 intravitreal injection with 50ul ACM-1 at a concentration of 1600ug/ml |
Withdrawn |
: Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID). : Choroidal Neovascularization in Angioid Streaks : 2015-10-07 : Drug: Aflibercept The patients are followed on a monthly basis until 52 weeks. Intravitreal injections o |